Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	117.13	248.55	114.47
Graham Fair Price	-28.86	2.41	3.39
PEG	69.26	-1.37	0.81
Price/Book	-17.74	1.47	1.79
Price/Cash Flow	68.56	-12.35	-39.29
Prices/Earnings	77.55	105.75	59.56
Price/Sales	-13.92	11.02	12.80
Price/FCF	68.56	-12.35	-39.29
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-21.24	0.18	0.22
Operating Margin	-67.67	0.02	0.07
ROA	-56.47	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-53.67
ROIC	< 0.005	< 0.005	-69.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.48	-0.07	570.25
Dividends QOQ	< 0.005	< 0.005	-42.08
EBIT QOQ	-0.20	-0.69	-242.15
EPS QOQ	0.73	-0.77	4.90
FCF QOQ	-0.17	-1.61	-838.09
Revenue QOQ	0.05	-0.05	0.58
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	138.56	154.17	11.26
Days Sales Outstanding (DSO)	133.28	153.55	15.21
Inventory Turnover	0.65	0.58	-10.12
Debt/Capitalization	0.23	0.31	33.38
Quick Ratio	1.12	0.97	-13.30
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	8.23	8.60	4.52
Cash	3.12	2.85	-8.81
Capex	-0.49	-0.74	-51.05
Free Cash Flow	-0.38	-1.03	-173.49
Revenue	1.15	1.15	-0.12
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.47	1.35	-7.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.59	20.89	481.52
Naive Interpretation	Member

06 - Financial Health · Weak

Rating